Published in J Biol Chem on April 08, 1994
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A (1998) 16.04
Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med (1999) 3.48
Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. EMBO J (1996) 2.37
Alternative splicing in the differentiation of human embryonic stem cells into cardiac precursors. PLoS Comput Biol (2009) 1.57
Fyn: a novel molecular target in cancer. Cancer (2010) 1.40
Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation. J Biol Chem (2006) 1.09
Caffeic acid, a phenolic phytochemical in coffee, directly inhibits Fyn kinase activity and UVB-induced COX-2 expression. Carcinogenesis (2008) 1.07
Unique catalytic properties dictate the enhanced function of p59fynT, the hemopoietic cell-specific isoform of the Fyn tyrosine protein kinase, in T cells. Mol Cell Biol (1994) 0.91
The unique amino-terminal domain of p56lck regulates interactions with tyrosine protein phosphatases in T lymphocytes. Mol Cell Biol (1995) 0.91
Lck-dependent Fyn activation requires C terminus-dependent targeting of kinase-active Lck to lipid rafts. J Biol Chem (2008) 0.84
Expression and activity of Fyn mediate proliferation and blastic features of chronic myelogenous leukemia. PLoS One (2012) 0.80
The Fyn-ADAP Axis: Cytotoxicity Versus Cytokine Production in Killer Cells. Front Immunol (2015) 0.79
Lck domains differentially contribute to pre-T cell receptor (TCR)- and TCR-alpha/beta-regulated developmental transitions. J Exp Med (2000) 0.77
TCR Triggering Induces the Formation of Lck-RACK1-Actinin-1 Multiprotein Network Affecting Lck Redistribution. Front Immunol (2016) 0.75
Neuroprotective Effects of Inhibiting Fyn S-Nitrosylation on Cerebral Ischemia/Reperfusion-Induced Damage to CA1 Hippocampal Neurons. Int J Mol Sci (2016) 0.75
Profound block in thymocyte development in mice lacking p56lck. Nature (1992) 5.48
Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med (1999) 3.48
Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. EMBO J (1996) 2.37
Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck. Nature (1991) 2.15
The Syk protein tyrosine kinase is essential for Fcgamma receptor signaling in macrophages and neutrophils. Mol Cell Biol (1998) 2.10
Negative regulation of T-cell receptor signalling by tyrosine protein kinase p50csk. Nature (1993) 2.05
Activation of pp60c-src protein kinase activity in human colon carcinoma. Proc Natl Acad Sci U S A (1987) 1.92
Association of tyrosine kinase p56lck with CD4 inhibits the induction of growth through the alpha beta T-cell receptor. Nature (1992) 1.81
Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nat Immunol (2001) 1.71
Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling. Mol Cell Biol (2000) 1.68
Proximal protein tyrosine kinases in immunoreceptor signaling. Curr Opin Immunol (2001) 1.67
Sequence requirements for association of protein-tyrosine phosphatase PEP with the Src homology 3 domain of inhibitory tyrosine protein kinase p50(csk). J Biol Chem (1998) 1.66
Inability of CD8 alpha' polypeptides to associate with p56lck correlates with impaired function in vitro and lack of expression in vivo. Nature (1989) 1.66
Differential regulation of T cell antigen responsiveness by isoforms of the src-related tyrosine protein kinase p59fyn. J Exp Med (1992) 1.62
Activation of p56lck through mutation of a regulatory carboxy-terminal tyrosine residue requires intact sites of autophosphorylation and myristylation. Mol Cell Biol (1990) 1.57
Direct association of protein-tyrosine phosphatase PTP-PEST with paxillin. J Biol Chem (1998) 1.51
A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins. Transfusion (2001) 1.49
The carboxyl-terminal region of biliary glycoprotein controls its tyrosine phosphorylation and association with protein-tyrosine phosphatases SHP-1 and SHP-2 in epithelial cells. J Biol Chem (1999) 1.46
Inhibitory tyrosine protein kinase p50csk is associated with protein-tyrosine phosphatase PTP-PEST in hemopoietic and non-hemopoietic cells. J Biol Chem (1997) 1.34
Regulation of the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck by the non-catalytic SH2 and SH3 domains. Oncogene (1992) 1.34
Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases. J Biol Chem (1996) 1.33
Association of tyrosine protein kinase Zap-70 with the protooncogene product p120c-cbl in T lymphocytes. J Exp Med (1996) 1.32
Analysis of pp60c-src in human colon carcinoma and normal human colon mucosal cells. Oncogene Res (1987) 1.29
PTP-PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates. EMBO J (2001) 1.25
Association of biliary glycoprotein with protein tyrosine phosphatase SHP-1 in malignant colon epithelial cells. Oncogene (1997) 1.25
Downregulation of Lck-mediated signal transduction by tip of herpesvirus saimiri. J Virol (1995) 1.21
Regulation of mouse PECAM-1 tyrosine phosphorylation by the Src and Csk families of protein-tyrosine kinases. J Biol Chem (1998) 1.21
The CD4 associated tyrosine protein kinase p56lck is positively regulated through its site of autophosphorylation. Oncogene (1990) 1.20
Structural requirements for enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck. Mol Cell Biol (1992) 1.20
Comparison of p56lck and p59fyn protein expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid cell lines. J Immunol (1995) 1.20
The Src and Csk families of tyrosine protein kinases in hemopoietic cells. Semin Immunol (1995) 1.14
Requirement of the SH3 and SH2 domains for the inhibitory function of tyrosine protein kinase p50csk in T lymphocytes. Mol Cell Biol (1995) 1.14
Regulation of T-cell antigen receptor signalling by Syk tyrosine protein kinase. Mol Cell Biol (1997) 1.12
17 beta-estradiol regulates and v-Ha-ras transfection constitutively enhances MCF7 breast cancer cell interactions with basement membrane. Proc Natl Acad Sci U S A (1986) 1.07
Genetic evidence for a tyrosine kinase cascade preceding the mitogen-activated protein kinase cascade in vertebrate G protein signaling. J Biol Chem (1997) 1.07
The SH2 domain is required for stable phosphorylation of p56lck at tyrosine 505, the negative regulatory site. Mol Cell Biol (1993) 1.03
Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins. Oncogene (1993) 1.02
Zinc is essential for binding of p56(lck) to CD4 and CD8alpha. J Biol Chem (1998) 1.01
A unique insert in the linker domain of Syk is necessary for its function in immunoreceptor signalling. EMBO J (1998) 1.01
Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein. J Virol Methods (2000) 1.00
Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells. J Immunol (1997) 0.99
A function for the lck proto-oncogene. Trends Biochem Sci (1989) 0.99
Regulation of SOCS-1 expression by translational repression. J Biol Chem (2000) 0.98
Clnk, a novel SLP-76-related adaptor molecule expressed in cytokine-stimulated hemopoietic cells. J Exp Med (1999) 0.98
Tyrosine phosphorylation of GAP and GAP-associated proteins in lymphoid and fibroblast cells expressing lck. Oncogene (1991) 0.97
Conserved cysteine residues are critical for the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck. J Biol Chem (1993) 0.93
Signal transduction by the lymphocyte-specific tyrosine protein kinase p56lck. Curr Top Microbiol Immunol (1996) 0.93
SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF. Mol Cell Biol (2001) 0.92
src-related protein tyrosine kinases. Cancer Treat Res (1989) 0.92
Ntk: a Csk-related protein-tyrosine kinase expressed in brain and T lymphocytes. Proc Natl Acad Sci U S A (1994) 0.92
The unique amino-terminal domain of p56lck regulates interactions with tyrosine protein phosphatases in T lymphocytes. Mol Cell Biol (1995) 0.91
Two distinct protein isoforms are encoded by ntk, a csk-related tyrosine protein kinase gene. Oncogene (1994) 0.91
Unique catalytic properties dictate the enhanced function of p59fynT, the hemopoietic cell-specific isoform of the Fyn tyrosine protein kinase, in T cells. Mol Cell Biol (1994) 0.91
Reconstitution of interactions between protein-tyrosine phosphatase CD45 and tyrosine-protein kinase p56(lck) in nonlymphoid cells. J Biol Chem (1997) 0.90
Efficacy of monoclonal antibody against human recombinant tumor necrosis factor in E. coli-challenged swine. Am J Pathol (1992) 0.90
Synergistic regulation of immunoreceptor signaling by SLP-76-related adaptor Clnk and serine/threonine protein kinase HPK-1. Mol Cell Biol (2001) 0.90
Intramolecular and extramolecular mechanisms repress the catalytic function of p56lck in resting T-lymphocytes. J Biol Chem (1994) 0.88
Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cells. Oncogene Res (1989) 0.88
Design and synthesis of a novel class of histone deacetylase inhibitors. Bioorg Med Chem Lett (2001) 0.86
tkl is the avian homolog of the mammalian lck tyrosine protein kinase gene. Mol Cell Biol (1992) 0.86
Tyrosine protein kinases in T lymphocytes. Chem Immunol (1994) 0.86
Interleukin 2-mediated uncoupling of T cell receptor alpha/beta from CD3 signaling. J Exp Med (1998) 0.86
Regulation of Zap-70 by Src family tyrosine protein kinases in an antigen-specific T-cell line. J Biol Chem (1995) 0.85
[Proceedings: Mesangial glomerulonephritis with IgA deposits: study of serum immunoglobulins]. J Urol Nephrol (Paris) (1975) 0.85
Chk, a Csk family tyrosine protein kinase, exhibits Csk-like activity in fibroblasts, but not in an antigen-specific T-cell line. J Biol Chem (1997) 0.84
Clinical safety, tolerability, and pharmacokinetics of murine monoclonal antibody to human tumor necrosis factor-alpha. J Infect Dis (1994) 0.84
De novo-developed T cells have compromised response to existing alloantigens: using Ld-specific transgenic 2C T cells as tracers in a mouse heart transplantation model. J Immunol (1998) 0.83
TCR alpha beta-independent CD28 signaling and costimulation require non-CD4-associated Lck. J Immunol (1999) 0.82
The noncatalytic domain of protein-tyrosine phosphatase-PEST targets paxillin for dephosphorylation in vivo. J Biol Chem (2000) 0.82
IL-4 induced leucocyte trafficking in cynomolgus monkeys: correlation with expression of adhesion molecules and chemokine generation. Clin Exp Allergy (1996) 0.81
CD4 and p56lck can stably associate when co-expressed in NIH3T3 cells. Oncogene (1989) 0.81
Preparation and properties of alpha 1-proteinase inhibitor concentrate from human plasma. Vox Sang (1985) 0.77
[Letter: Changes in serum IgA in glomerulonephritis with IgA mesangial deposits]. Nouv Presse Med (1974) 0.77
The lymphocyte-specific tyrosine protein kinase p56lck. Cancer Invest (1991) 0.76
Study of septic shock in the non-human primate: relationship of pathophysiological response to therapy with anti-TNF antibody. Circ Shock (1994) 0.76
Association of CD45 with Lck and components of the Ras signalling pathway in pervanadate-treated mouse T-cell lines. Oncogene (1996) 0.75
Modulation of the cellular immune responses to T-cell-dependent and T cell-independent antigens in lambs with induced bovine viral diarrhea virus infection. Am J Vet Res (1989) 0.75
[Recent advances in pneumology]. Nouv Presse Med (1973) 0.75
[Clinical trial of a new neuroleptic derivative: flupentixo flupentixol, in hypochondriac depression]. Tunis Med (1974) 0.75